OlympicsTeva Pharmaceutical Industries
Jul 17, 2008
Teva Enrolls Patients For A Second Large Global Phase III Trial Of Oral Laquinimod
Teva Pharmaceutical Industries Ltd. and Active Biotech AB announced that patients are being enrolled for the BRAVO Phase III pivotal trial.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Teva Announces Tentative Approval of Generic Pr... (from Jan '08) | Aug 15 | Larry | 7 |
| Teva Announces Launch of Generic Zoloft (from Nov '06) | Aug 14 | Rebecca | 1090 |
| Teva Announces Launch of Generic Protonix Table... (from Jan '08) | Aug 7 | Daffodil | 20 |
| Study shows Teva's laquinimod slows MS | Jun '08 | WEL | 1 |
| Teva Announces Launch Of Generic Wellbutrin XL(... | Jun '08 | jmb | 1 |
| FDA says generic Wellbutrin OK despite reports | Apr '08 | Greg | 1 |
| Drug Side Effects, Fatalities Are Increasing in... | Apr '08 | ben | 2 |
Gemini
Most Popular